Format

Send to

Choose Destination
Neurosurg Focus. 2016 May;40(5):E2. doi: 10.3171/2016.2.FOCUS15637.

Neurorestoration after stroke.

Author information

1
Department of Neurosurgery, Stanford University School of Medicine, Stanford, California.

Abstract

Recent advancements in stem cell biology and neuromodulation have ushered in a battery of new neurorestorative therapies for ischemic stroke. While the understanding of stroke pathophysiology has matured, the ability to restore patients' quality of life remains inadequate. New therapeutic approaches, including cell transplantation and neurostimulation, focus on reestablishing the circuits disrupted by ischemia through multidimensional mechanisms to improve neuroplasticity and remodeling. The authors provide a broad overview of stroke pathophysiology and existing therapies to highlight the scientific and clinical implications of neurorestorative therapies for stroke.

KEYWORDS:

BCI = brain-computer interface; G-CSF = granulocyte colony-stimulating factor; MSC = mesenchymal stem cell; NPC = neural progenitor cell; NSC = neural stem cell; NT2N = Ntera2/D1 neuron-like; PSD-95 = postsynaptic density-95; RCT = randomized controlled trial; TMS = transcranial magnetic stimulation; brain-computer interface; exogenous stem cells; neuroplasticity; optogenetics; tDCS = transcranial direct current stimulation; tPA = tissue plasminogen activator

PMID:
27132523
PMCID:
PMC4916840
DOI:
10.3171/2016.2.FOCUS15637
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center